Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination

The increasing effectiveness of new disease-modifying drugs that suppress disease activity in multiple sclerosis has opened up opportunities for regenerative medicines that enhance remyelination and potentially slow disease progression. Although several new targets for therapeutic enhancement of rem...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Syed, Yasir A, Baer, Alexandra, Hofer, Matthias P, González, Ginez A, Rundle, Jon, Myrta, Szymon, Huang, Jeffrey K, Zhao, Chao, Rossner, Moritz J, Trotter, Matthew W B, Lubec, Gert, Franklin, Robin J M, Kotter, Mark R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons 2013
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3914530/
https://ncbi.nlm.nih.gov/pubmed/24293318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201303123
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak